Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Chemed Corp

Bernstein analyst Bob Brackett maintained a Hold rating on Chevron today and set a price target of $216.00. According to TipRanks, Brackett is a 5-...

Bernstein Sticks to Their Hold Rating for Chevron (CVX)

In a report released today, from Ord Minnett maintained a Hold rating on Beach Energy , with a price target of A$1.22. In addition to Ord Minnett, ...

Ord Minnett Sticks to Their Hold Rating for Beach Energy  (BEPTF)

Cochlear ( ($AU:COH) ) has provided an update. Cochlear Limited has notified the market of the cessation of several classes of equity-linked securi...

Cochlear Reports Lapse and Expiry of Equity Incentive Securities

An announcement from Cochlear ( ($AU:COH) ) is now available. Cochlear Limited has issued 6,196 new fully paid ordinary shares on 31 March 2026 fol...

Cochlear Issues 6,196 New Shares Following Conversion of Unquoted Securities

The latest announcement is out from Cochlear ( ($AU:COH) ). Cochlear Limited has notified the market of the issue of 8,156 unquoted service rights ...

Cochlear Issues New Unquoted Service Rights Under Employee Incentive Plan

Cochlear ( ($AU:COH) ) has shared an update. The Bank of New York Mellon Corporation and its related group entities have notified Cochlear Ltd that...

BNY Mellon Ceases to Be Substantial Shareholder in Cochlear

Macquarie analyst maintained a Sell rating on Beach Energy today and set a price target of A$0.77. In addition to Macquarie, Beach Energy also rece...

Macquarie Reaffirms Their Sell Rating on Beach Energy  (BEPTF)

An update from Charging Robotics ( ($CHEV) ) is now available. On March 30, 2026, Charging Robotics Inc. reshaped its board by appointing Amir Nard...

Charging Robotics Revamps Board With New Strategic Directors

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbSci (ABSI) and Cochlear (CHEOF) with bullish senti...

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and Cochlear (OtherCHEOF)

In a report released on March 20, Biraj Borkhataria from RBC Capital maintained a Buy rating on Chevron, with a price target of $200.00. The compan...

RBC Capital Sticks to Their Buy Rating for Chevron (CVX)

In a report released on March 20, from Bernstein maintained a Hold rating on Chevron, with a price target of $216.00. The company’s shares closed l...

Bernstein Reaffirms Their Hold Rating on Chevron (CVX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Merck & Company (MRK), Chemed (CHE) and PROCEPT BioR...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Chemed (CHE) and PROCEPT BioRobotics (PRCT)

China Huarong Asset Management Co., Ltd. Class H ( ($HK:2799) ) has provided an announcement. China CITIC Financial Asset Management Co., Ltd. has ...

China CITIC Financial Asset Sets Date to Approve 2025 Annual Results

Barclays analyst Betty Jiang maintained a Hold rating on Chevron on March 13 and set a price target of $180.00. The company’s shares closed last Fr...

Barclays Reaffirms Their Hold Rating on Chevron (CVX)

Cochlear ( ($AU:COH) ) has shared an update. Pinnacle Investment Management Group Limited and its listed subsidiaries have notified Cochlear Ltd th...

Pinnacle Investment Exits Substantial Holder Position in Cochlear

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ramsay Health Care (RMSYF – Research Report) and C...

Current Quarter	$4.85	Next Quarter	$4.98
Current Year	$21.92	Next Year	$24.71
QoQ Growth	+2.7%	YoY Growth	+12.7%
3Y EPS CAGR	+5.5%	Target Price	$443.00
Consensus	Buy	Upside	+11.5%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CHE	$397.39	+2.17%	234.10K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CHE	$397.39	+2.2%	234.10K
3
4
5
6

CHE

CHE

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Chemed Corp Data in Excel

Get Chemed Corp Data in Excel